The Impact of Low Cardiac Output on Propofol Pharmacokinetics across Age Groups—An Investigation Using Physiologically Based Pharmacokinetic Modelling
Background: pathophysiological changes such as low cardiac output (LCO) impact pharmacokinetics, but its extent may be different throughout pediatrics compared to adults. Physiologically based pharmacokinetic (PBPK) modelling enables further exploration. Methods: A validated propofol model was used...
Main Authors: | Karel Allegaert, Mohammad Yaseen Abbasi, Robin Michelet, Olusola Olafuyi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/9/1957 |
Similar Items
-
Clinical pharmacokinetics of vancomycin in the neonate: a review
by: Gian Maria Pacifici, et al.
Published: (2012-07-01) -
Interdisciplinary Collaboration on Real World Data to Close the Knowledge Gap: A Reflection on “De Sutter et al. Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic Modelling”
by: Karel Allegaert, et al.
Published: (2024-01-01) -
Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic Modelling
by: Pieter-Jan De Sutter, et al.
Published: (2023-09-01) -
A Physiology-Based Pharmacokinetic Framework to Support Drug Development and Dose Precision During Therapeutic Hypothermia in Neonates
by: Anne Smits, et al.
Published: (2020-05-01) -
The determinants of propofol induction time in anesthesia
by: Yushi U. Adachi, et al.
Published: (2013-08-01)